60 SPXIQ

REGN Regeneron Pharmaceuticals, Inc.

Healthcare · Biotechnology

$783.38 +11.1% upside
Mean Target
$869.96
Consensus
1.7 - Buy
Analysts
26
Rank
#101 / 499
Upside Rank
#241
Analyst Price Target Distribution
$730
Low
$874
Median
$870
Mean
$1057
High
Current $783
Mean $870
Median $874
100 estimates
Consensus
1.7 - Buy
52-Wk Low
$476.49
52-Wk High
$821.11
50-Day Avg
$770.17
Recent Analyst Ratings
FirmRatingTargetPriorDate
Guggenheim Buy $975 $865 2026-02-09
JP Morgan Overweight $950 $850 2026-02-02
Oppenheimer Outperform $865 $750 2026-02-02
Morgan Stanley Equal-Weight $769 $768 2026-02-02
Wells Fargo Equal-Weight $800 $745 2026-02-02
Healthcare Peers